Developer docs
API playgroundTry for free, no card

Search company profiles

Ascent Pharmaceuticals

Full company profile

uuid000c6l6

Namestring
Ascent Pharmaceuticals
Legal namestring
Ascent Pharmaceuticals, Inc.
Websiteurl
ascentpharm.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Ascent Pharmaceuticals, Inc. is a privately held U.S. generic pharmaceutical manufacturer founded in June 2012 by Dr. Sudhakar Vidiyala and headquartered in Central Islip, New York. The company develops, manufactures, and analyzes a portfolio of 49 generic medicines spanning controlled substances (Schedule II opioids such as oxycodone, hydromorphone, methadone, and buprenorphine products), CNS stimulants (amphetamine, methylphenidate, lisdexamfetamine), antidepressants (SSRIs/SNRIs), anticonvulsants, lipid-lowering agents, and other therapeutic categories. It operates from a single cGMP-compliant facility of more than 309,000 square feet, producing multiple dosage forms including immediate-release, modified-release, and extended-release tablets, capsules, softgels, sublingual films, and oral solutions, supported by DEA registration for controlled substances.

The technology platform centers on advanced oral solid dose manufacturing with high-output equipment such as the KORSCH TRP 700 triple-layer tablet press capable of up to 198,000 tablets per hour, softgel production lines with precise filling and sealing controls, and integrated GMP-compliant packaging and finishing. The R&D function is supported by an India-based partner (Asphar Laboratories) for early-stage formulation and analytical development, while internal capabilities include patents covering abuse-deterrent oral dosage forms, oxygen- and moisture-sensitive blister packaging, progesterone compositions, and levothyroxine stabilization methods.

Ascent operates a pure B2B, asset-light commercial model in which finished products are marketed and distributed through channel partners rather than a direct sales force. Camber Pharmaceuticals serves as the primary commercial partner under the Camber brand, XLCare Pharmaceuticals handles U.S. government healthcare programs (Medicaid, Medicare, federal/state programs), and Lannett has appeared as an additional distribution channel. Pricing is contract-based and not publicly disclosed, with revenue generated through one-time sales of generic pharmaceutical units across therapeutic categories. End customers are healthcare providers and patients reached through standard pharmaceutical wholesale and distribution networks.

Short descriptiontext

Ascent Pharmaceuticals is a U.S. generic drug manufacturer founded in 2012, operating a 309,000+ sq ft cGMP facility in Central Islip, NY, producing 49 generic medicines including controlled substances and CNS stimulants for B2B distribution via Camber, XLCare, and Lannett.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCentral Islip, United States
HQ citystring
Central Islip
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, oral solid dosage forms, controlled substance medications, generic drug development, pharmaceutical contract manufacturing
Industry4 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Generic Pharmaceutical Product Sales
TypeOne Time License
Description

Revenue generated from manufacturing and selling generic pharmaceutical products across multiple therapeutic categories including controlled substances, CNS stimulants, opioids, and various other generic medications. Products are distributed through channel partners (Camber, XLCare) and directly under the Ascent brand.

ascentpharm.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Infrastructure, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Camber
Description

Ascent's commercial products are primarily marketed and distributed under the Camber brand.

ascentpharm.com
Core offering1 text field

Ascent Pharmaceuticals develops, manufactures, and analyzes high-quality generic medicines at a 309,000+ square foot cGMP-compliant facility in Central Islip, New York. The company produces a portfolio of 49 generic pharmaceutical products spanning multiple dosage forms (tablets, capsules, softgels, films, and oral solutions) across therapeutic categories including CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed and distributed primarily through channel partners Camber Pharmaceuticals and XLCare Pharmaceuticals, with select products sold under the Ascent brand.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ascent Pharmaceuticals is a generic pharmaceutical company that develops, manufactures, and distributes a broad portfolio of generic medicines. The company operates from a 309,000+ square foot cGMP-compliant facility in Central Islip, New York, producing multiple dosage forms including tablets, capsules, oral solutions, and films across therapeutic areas such as CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed primarily through commercial partners including Camber Pharmaceuticals, XLCare Pharmaceuticals, and Lannett, with select products sold under the Ascent brand. The portfolio of 49+ generic products includes treatments for ADHD (Amphetamine ER, Methylphenidate), pain management (Hydrocodone, Oxycodone, Hydromorphone), opioid use disorder (Buprenorphine products), mental health (Escitalopram, Sertraline, Paliperidone), and various other therapeutic categories.

Product and service49 records
1Amphetamine ER Capsules
CategoryGeneric Pharmaceutical Product
Description

Extended-release amphetamine capsules for the treatment of ADHD and narcolepsy, available in multiple dosage strengths (5mg-30mg).

2Amphetamine Tablets
CategoryGeneric Pharmaceutical Product
Description

Immediate-release amphetamine tablets for ADHD treatment, available in 5mg-30mg strengths.

3Benzonatate Capsules
CategoryGeneric Pharmaceutical Product
Description

Antitussive capsules for symptomatic relief of cough, available in 100mg, 150mg, and 200mg strengths.

4Bexarotene Capsules
CategoryGeneric Pharmaceutical Product
Description

Retinoid capsules for cutaneous T-cell lymphoma treatment, 75mg strength.

5Buprenorphine Naloxone Sublingual Film
CategoryGeneric Pharmaceutical Product
Description

Opioid use disorder treatment film in multiple dosage combinations (2mg/0.5mg to 12mg/3mg).

6Buprenorphine Naloxone Sublingual Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid use disorder treatment tablets in 2mg/0.5mg and 8mg/2mg strengths.

7Buprenorphine Sublingual Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid agonist tablets for opioid dependence treatment in 2mg and 8mg strengths.

8Carbidopa and Levodopa Tablets
CategoryGeneric Pharmaceutical Product
Description

Decarboxylase inhibitor combination tablets for Parkinson's disease treatment in multiple strength combinations.

9Dexmethylphenidate HCl ER Capsules
CategoryGeneric Pharmaceutical Product
Description

Extended-release stimulant capsules for ADHD treatment, available in 5mg-40mg strengths.

10Dronabinol Capsules
CategoryGeneric Pharmaceutical Product
Description

Cannabinoid capsules for nausea/vomiting associated with chemotherapy and appetite stimulation in HIV/AIDS, 2.5mg-10mg strengths.

11Dutasteride Capsules
CategoryGeneric Pharmaceutical Product
Description

Benign prostatic hyperplasia treatment capsules, 0.5mg strength.

12Escitalopram Tablets
CategoryGeneric Pharmaceutical Product
Description

SSRI antidepressant tablets for depression and anxiety disorders in 5mg-20mg strengths.

13Famotidine OTC Tablets
CategoryGeneric Pharmaceutical Product
Description

Over-the-counter H2 receptor antagonist tablets for heartburn relief, 10mg and 20mg strengths.

14Famotidine Rx Tablets
CategoryGeneric Pharmaceutical Product
Description

Prescription H2 receptor antagonist tablets, 20mg and 40mg strengths.

15Gabapentin Capsules
CategoryGeneric Pharmaceutical Product
Description

Anticonvulsant capsules for epilepsy and neuropathic pain, 100mg-400mg strengths.

16Gabapentin Tablets
CategoryGeneric Pharmaceutical Product
Description

Anticonvulsant tablets for epilepsy and neuropathic pain, 600mg and 800mg strengths.

17Gemfibrozil Tablets
CategoryGeneric Pharmaceutical Product
Description

Fibric acid derivative tablets for hyperlipidemia treatment, 600mg strength.

18Hydrocodone Bitartrate and Acetaminophen Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid analgesic combination tablets for moderate to severe pain, available in 2.5mg/325mg to 10mg/325mg strengths.

19Hydromorphone HCl ER Tablets
CategoryGeneric Pharmaceutical Product
Description

Extended-release opioid analgesic tablets for severe pain, 8mg-32mg strengths.

20Hydromorphone HCl Oral Solution
CategoryGeneric Pharmaceutical Product
Description

Narcotic analgesic oral solution, 1mg/mL strength in 473mL containers.

21Hydromorphone HCl Tablets
CategoryGeneric Pharmaceutical Product
Description

Immediate-release narcotic analgesic tablets, 2mg-8mg strengths.

22Ibuprofen and Famotidine Tablets
CategoryGeneric Pharmaceutical Product
Description

NSAID/H2-receptor antagonist combination tablets for pain relief with reduced gastric risk, 800mg/26.6mg strength.

23Ibuprofen Capsules
CategoryGeneric Pharmaceutical Product
Description

NSAID capsules for pain and inflammation relief, 200mg strength.

24Icosapent Ethyl Capsules
CategoryGeneric Pharmaceutical Product
Description

Lipid-lowering agent capsules for cardiovascular risk reduction, 0.5g and 1g strengths.

25Levothyroxine Sodium Tablets
CategoryGeneric Pharmaceutical Product
Description

Synthetic thyroid hormone tablets for hypothyroidism, available in 25mcg-300mcg strengths.

26Lisdexamphetamine Dimesylate Capsules
CategoryGeneric Pharmaceutical Product
Description

Stimulant prodrug capsules for ADHD treatment, 10mg-70mg strengths.

27Lisdexamphetamine Dimesylate Chewable Tablets
CategoryGeneric Pharmaceutical Product
Description

Chewable stimulant tablets for ADHD treatment in patients who have difficulty swallowing.

28Lubiprostone Capsules
CategoryGeneric Pharmaceutical Product
Description

Chloride channel activator capsules for chronic idiopathic constipation and IBS, 8mcg and 24mcg strengths.

29Meloxicam Tablets
CategoryGeneric Pharmaceutical Product
Description

NSAID tablets for osteoarthritis and rheumatoid arthritis, 7.5mg and 15mg strengths.

30Methadone HCl Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid analgesic tablets for pain management and opioid use disorder treatment.

31Methylphenidate HCl Chewable Tablets
CategoryGeneric Pharmaceutical Product
Description

CNS stimulant chewable tablets for ADHD, 2.5mg-10mg strengths.

32Methylphenidate HCl ER Tablets
CategoryGeneric Pharmaceutical Product
Description

Extended-release CNS stimulant tablets for ADHD, 18mg-54mg strengths.

33Methylphenidate HCl Oral Solution
CategoryGeneric Pharmaceutical Product
Description

CNS stimulant oral solution, 5mg/5mL and 10mg/5mL strengths.

34Methylphenidate Tablets
CategoryGeneric Pharmaceutical Product
Description

Immediate-release CNS stimulant tablets for ADHD, 5mg-20mg strengths.

35Omega Caps (Omega-3 Acid Ethyl Esters)
CategoryGeneric Pharmaceutical Product
Description

Antihyperlipidemic omega-3 fatty acid capsules for hypertriglyceridemia, 1g strength.

36Oxycodone and Acetaminophen Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid analgesic combination tablets for moderate to severe pain.

37Oxycodone HCl Oral Solution
CategoryGeneric Pharmaceutical Product
Description

Narcotic analgesic oral solution, 5mg/5mL strength.

38Oxycodone HCl Tablets
CategoryGeneric Pharmaceutical Product
Description

Narcotic analgesic tablets, 5mg-30mg strengths.

39Oxymorphone HCl Tablets
CategoryGeneric Pharmaceutical Product
Description

Opioid analgesic tablets for moderate to severe pain, 5mg and 10mg strengths.

40Paliperidone ER Tablets
CategoryGeneric Pharmaceutical Product
Description

Atypical antipsychotic extended-release tablets for schizophrenia treatment, 1.5mg-9mg strengths.

41Potassium Chloride ER Tablets
CategoryGeneric Pharmaceutical Product
Description

Electrolyte supplement extended-release tablets for hypokalemia, 10mEq-20mEq strengths.

42Potassium Chloride Oral Solution
CategoryGeneric Pharmaceutical Product
Description

Electrolyte supplement oral solution for hypokalemia, 10% and 20% concentrations.

43Potassium Citrate ER Tablets
CategoryGeneric Pharmaceutical Product
Description

Electrolyte supplement extended-release tablets for renal tubular acidosis, 5mEq-15mEq strengths.

44Rivaroxaban Tablets
CategoryGeneric Pharmaceutical Product
Description

Anticoagulant tablets for blood clot prevention, 2.5mg and 10mg strengths.

45Sertraline HCl Tablets
CategoryGeneric Pharmaceutical Product
Description

SSRI antidepressant tablets for depression, PTSD, and anxiety disorders, 25mg-100mg strengths.

46Sodium Oxybate Oral Solution
CategoryGeneric Pharmaceutical Product
Description

CNS depressant oral solution for narcolepsy (cataplexy) and excessive daytime sleepiness, 0.5g/mL strength.

47Tamsulosin HCl Capsules
CategoryGeneric Pharmaceutical Product
Description

Alpha-1 adrenergic receptor antagonist capsules for BPH, 0.4mg strength.

48Topiramate Tablets
CategoryGeneric Pharmaceutical Product
Description

Anticonvulsant tablets for epilepsy and migraine prevention, 25mg-200mg strengths.

49Venlafaxine ER Tablets
CategoryGeneric Pharmaceutical Product
Description

SNRI extended-release tablets for depression and anxiety disorders, 37.5mg-225mg strengths.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Strategic commercial partnership where Ascent's manufacturing excellence and supply execution capabilities are combined with Camber's commercial leadership, marketing strength, and customer-facing expertise. Ascent's commercial products are primarily marketed and distributed under the Camber brand, enabling a coordinated, reliable, and market-responsive approach to serving healthcare partners nationwide.

2XLCare Pharmaceuticals
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with XLCare Pharmaceuticals to support U.S. government healthcare programs and the patients and communities they serve, including Medicaid, Medicare, and other federal/state healthcare programs.

ascentpharm.com
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

India-based R&D counterpart that collaborates with Ascent Pharmaceuticals to support select early-stage formulation and analytical development, enhancing Ascent's product development pipeline.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based generic pharmaceutical manufacturer of comparable scale with a portfolio overlapping Ascent's CNS stimulant, opioid, and cardiovascular generics. Lannett is one of Ascent's distribution channel partners, underscoring direct comparability in product mix and customer base.

TypeDirect peer
Description

US-headquartered generic and specialty pharmaceutical company with a portfolio that directly overlaps Ascent's CNS stimulant, opioid, and injectable offerings. Comparable scale, US manufacturing footprint, and exposure to complex generics and controlled substances.

3Endo International
TypeBroad incumbent
Description

US specialty/generic pharma company with a strong controlled-substance and pain-management franchise (Par Pharmaceutical). Comparable focus on Schedule II generics and complex formulations at greater scale.

TypeRegional player
Description

Canadian-headquartered generic manufacturer with a sizable US business across tablets, capsules, and oral solutions. Overlapping product formats and therapeutic categories, with a comparable focus on quality manufacturing and regulated markets.

TypeBroad incumbent
Description

US generics arm of Cadila/Zydus, an India-based group with deep R&D ties to Ascent's partner Asphar Laboratories. Portfolio overlaps significantly across cardiovascular, CNS, and pain generics.

TypeDirect peer
Description

Sister-concern US generic distributor (also under Hetero Labs) and Ascent's primary commercial channel partner. Operates a near-identical generic portfolio across controlled substances, CNS, and pain management — competing head-to-head in the same molecules and customer accounts.

TypeBroad incumbent
Description

US arm of one of the largest global generic manufacturers. Overlaps with Ascent across multiple therapeutic categories and dosage forms, but at substantially greater scale and breadth — a relevant comparable for trajectory benchmarking.

TypeDirect peer
Description

India-headquartered generic manufacturer with a meaningful US commercial presence. Overlapping dosage forms (tablets, capsules, oral solutions) and therapeutic categories including CNS, cardiovascular, and pain.

9Sun Pharmaceutical Industries (US)
TypeBroad incumbent
Description

India-headquartered global generics leader with significant US operations through Taro Pharmaceutical. Overlaps with Ascent across CNS, cardiovascular, and pain categories; relevant for scale and capacity benchmarking.

TypeDirect peer
Description

US generics subsidiary of Alkem Laboratories with a portfolio and operational footprint closely aligned with Ascent's — private-equity-backed, broad therapeutic mix, and India-linked R&D support. Competes for the same ANDA opportunities and channel relationships.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ascent Pharmaceuticals

Generic Pharmaceuticalsascentpharm.com

Ascent Pharmaceuticals is a U.S. generic drug manufacturer founded in 2012, operating a 309,000+ sq ft cGMP facility in Central Islip, NY, producing 49 generic medicines including controlled substances and CNS stimulants for B2B distribution via Camber, XLCare, and Lannett.

What Ascent Pharmaceuticals does

Ascent Pharmaceuticals, Inc. is a privately held U.S. generic pharmaceutical manufacturer founded in June 2012 by Dr. Sudhakar Vidiyala and headquartered in Central Islip, New York. The company develops, manufactures, and analyzes a portfolio of 49 generic medicines spanning controlled substances (Schedule II opioids such as oxycodone, hydromorphone, methadone, and buprenorphine products), CNS stimulants (amphetamine, methylphenidate, lisdexamfetamine), antidepressants (SSRIs/SNRIs), anticonvulsants, lipid-lowering agents, and other therapeutic categories. It operates from a single cGMP-compliant facility of more than 309,000 square feet, producing multiple dosage forms including immediate-release, modified-release, and extended-release tablets, capsules, softgels, sublingual films, and oral solutions, supported by DEA registration for controlled substances.

The technology platform centers on advanced oral solid dose manufacturing with high-output equipment such as the KORSCH TRP 700 triple-layer tablet press capable of up to 198,000 tablets per hour, softgel production lines with precise filling and sealing controls, and integrated GMP-compliant packaging and finishing. The R&D function is supported by an India-based partner (Asphar Laboratories) for early-stage formulation and analytical development, while internal capabilities include patents covering abuse-deterrent oral dosage forms, oxygen- and moisture-sensitive blister packaging, progesterone compositions, and levothyroxine stabilization methods.

Ascent operates a pure B2B, asset-light commercial model in which finished products are marketed and distributed through channel partners rather than a direct sales force. Camber Pharmaceuticals serves as the primary commercial partner under the Camber brand, XLCare Pharmaceuticals handles U.S. government healthcare programs (Medicaid, Medicare, federal/state programs), and Lannett has appeared as an additional distribution channel. Pricing is contract-based and not publicly disclosed, with revenue generated through one-time sales of generic pharmaceutical units across therapeutic categories. End customers are healthcare providers and patients reached through standard pharmaceutical wholesale and distribution networks.

Ascent Pharmaceuticals firmographics

Firmographics
Name
Ascent Pharmaceuticals
Legal name
Ascent Pharmaceuticals, Inc.
Website
https://ascentpharm.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
101–250 employees
Short description
Ascent Pharmaceuticals is a U.S. generic drug manufacturer founded in 2012, operating a 309,000+ sq ft cGMP facility in Central Islip, NY, producing 49 generic medicines including controlled substances and CNS stimulants for B2B distribution via Camber, XLCare, and Lannett.
Ownership category
akta.pro rank

Ascent Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Generic pharmaceutical manufacturing
  • Oral solid dosage forms
  • Controlled substance medications
  • Generic drug development
  • Pharmaceutical contract manufacturing

Where Ascent Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Central Islip
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Ascent Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Generic Pharmaceutical Product Sales: Revenue generated from manufacturing and selling generic pharmaceutical products across multiple therapeutic categories including controlled substances, CNS stimulants, opioids, and various other generic medications. Products are distributed through channel partners (Camber, XLCare) and directly under the Ascent brand.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Ascent Pharmaceuticals product offering

Product offering

Core offering

Ascent Pharmaceuticals develops, manufactures, and analyzes high-quality generic medicines at a 309,000+ square foot cGMP-compliant facility in Central Islip, New York. The company produces a portfolio of 49 generic pharmaceutical products spanning multiple dosage forms (tablets, capsules, softgels, films, and oral solutions) across therapeutic categories including CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed and distributed primarily through channel partners Camber Pharmaceuticals and XLCare Pharmaceuticals, with select products sold under the Ascent brand.

Product overview

Ascent Pharmaceuticals is a generic pharmaceutical company that develops, manufactures, and distributes a broad portfolio of generic medicines. The company operates from a 309,000+ square foot cGMP-compliant facility in Central Islip, New York, producing multiple dosage forms including tablets, capsules, oral solutions, and films across therapeutic areas such as CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed primarily through commercial partners including Camber Pharmaceuticals, XLCare Pharmaceuticals, and Lannett, with select products sold under the Ascent brand. The portfolio of 49+ generic products includes treatments for ADHD (Amphetamine ER, Methylphenidate), pain management (Hydrocodone, Oxycodone, Hydromorphone), opioid use disorder (Buprenorphine products), mental health (Escitalopram, Sertraline, Paliperidone), and various other therapeutic categories.

Differentiator

Problem solved

Functional benefit

Brands

  • Camber: Ascent's commercial products are primarily marketed and distributed under the Camber brand.

Products and services

  • Amphetamine ER Capsules Extended-release amphetamine capsules for the treatment of ADHD and narcolepsy, available in multiple dosage strengths (5mg-30mg).
  • Amphetamine Tablets Immediate-release amphetamine tablets for ADHD treatment, available in 5mg-30mg strengths.
  • Benzonatate Capsules Antitussive capsules for symptomatic relief of cough, available in 100mg, 150mg, and 200mg strengths.
  • Bexarotene Capsules Retinoid capsules for cutaneous T-cell lymphoma treatment, 75mg strength.
  • Buprenorphine Naloxone Sublingual Film Opioid use disorder treatment film in multiple dosage combinations (2mg/0.5mg to 12mg/3mg).
  • Buprenorphine Naloxone Sublingual Tablets Opioid use disorder treatment tablets in 2mg/0.5mg and 8mg/2mg strengths.
  • Buprenorphine Sublingual Tablets Opioid agonist tablets for opioid dependence treatment in 2mg and 8mg strengths.
  • Carbidopa and Levodopa Tablets Decarboxylase inhibitor combination tablets for Parkinson's disease treatment in multiple strength combinations.
  • Dexmethylphenidate HCl ER Capsules Extended-release stimulant capsules for ADHD treatment, available in 5mg-40mg strengths.
  • Dronabinol Capsules Cannabinoid capsules for nausea/vomiting associated with chemotherapy and appetite stimulation in HIV/AIDS, 2.5mg-10mg strengths.
  • Dutasteride Capsules Benign prostatic hyperplasia treatment capsules, 0.5mg strength.
  • Escitalopram Tablets SSRI antidepressant tablets for depression and anxiety disorders in 5mg-20mg strengths.
  • Famotidine OTC Tablets Over-the-counter H2 receptor antagonist tablets for heartburn relief, 10mg and 20mg strengths.
  • Famotidine Rx Tablets Prescription H2 receptor antagonist tablets, 20mg and 40mg strengths.
  • Gabapentin Capsules Anticonvulsant capsules for epilepsy and neuropathic pain, 100mg-400mg strengths.
  • Gabapentin Tablets Anticonvulsant tablets for epilepsy and neuropathic pain, 600mg and 800mg strengths.
  • Gemfibrozil Tablets Fibric acid derivative tablets for hyperlipidemia treatment, 600mg strength.
  • Hydrocodone Bitartrate and Acetaminophen Tablets Opioid analgesic combination tablets for moderate to severe pain, available in 2.5mg/325mg to 10mg/325mg strengths.
  • Hydromorphone HCl ER Tablets Extended-release opioid analgesic tablets for severe pain, 8mg-32mg strengths.
  • Hydromorphone HCl Oral Solution Narcotic analgesic oral solution, 1mg/mL strength in 473mL containers.
  • Hydromorphone HCl Tablets Immediate-release narcotic analgesic tablets, 2mg-8mg strengths.
  • Ibuprofen and Famotidine Tablets NSAID/H2-receptor antagonist combination tablets for pain relief with reduced gastric risk, 800mg/26.6mg strength.
  • Ibuprofen Capsules NSAID capsules for pain and inflammation relief, 200mg strength.
  • Icosapent Ethyl Capsules Lipid-lowering agent capsules for cardiovascular risk reduction, 0.5g and 1g strengths.
  • Levothyroxine Sodium Tablets Synthetic thyroid hormone tablets for hypothyroidism, available in 25mcg-300mcg strengths.
  • Lisdexamphetamine Dimesylate Capsules Stimulant prodrug capsules for ADHD treatment, 10mg-70mg strengths.
  • Lisdexamphetamine Dimesylate Chewable Tablets Chewable stimulant tablets for ADHD treatment in patients who have difficulty swallowing.
  • Lubiprostone Capsules Chloride channel activator capsules for chronic idiopathic constipation and IBS, 8mcg and 24mcg strengths.
  • Meloxicam Tablets NSAID tablets for osteoarthritis and rheumatoid arthritis, 7.5mg and 15mg strengths.
  • Methadone HCl Tablets Opioid analgesic tablets for pain management and opioid use disorder treatment.
  • Methylphenidate HCl Chewable Tablets CNS stimulant chewable tablets for ADHD, 2.5mg-10mg strengths.
  • Methylphenidate HCl ER Tablets Extended-release CNS stimulant tablets for ADHD, 18mg-54mg strengths.
  • Methylphenidate HCl Oral Solution CNS stimulant oral solution, 5mg/5mL and 10mg/5mL strengths.
  • Methylphenidate Tablets Immediate-release CNS stimulant tablets for ADHD, 5mg-20mg strengths.
  • Omega Caps (Omega-3 Acid Ethyl Esters) Antihyperlipidemic omega-3 fatty acid capsules for hypertriglyceridemia, 1g strength.
  • Oxycodone and Acetaminophen Tablets Opioid analgesic combination tablets for moderate to severe pain.
  • Oxycodone HCl Oral Solution Narcotic analgesic oral solution, 5mg/5mL strength.
  • Oxycodone HCl Tablets Narcotic analgesic tablets, 5mg-30mg strengths.
  • Oxymorphone HCl Tablets Opioid analgesic tablets for moderate to severe pain, 5mg and 10mg strengths.
  • Paliperidone ER Tablets Atypical antipsychotic extended-release tablets for schizophrenia treatment, 1.5mg-9mg strengths.
  • Potassium Chloride ER Tablets Electrolyte supplement extended-release tablets for hypokalemia, 10mEq-20mEq strengths.
  • Potassium Chloride Oral Solution Electrolyte supplement oral solution for hypokalemia, 10% and 20% concentrations.
  • Potassium Citrate ER Tablets Electrolyte supplement extended-release tablets for renal tubular acidosis, 5mEq-15mEq strengths.
  • Rivaroxaban Tablets Anticoagulant tablets for blood clot prevention, 2.5mg and 10mg strengths.
  • Sertraline HCl Tablets SSRI antidepressant tablets for depression, PTSD, and anxiety disorders, 25mg-100mg strengths.
  • Sodium Oxybate Oral Solution CNS depressant oral solution for narcolepsy (cataplexy) and excessive daytime sleepiness, 0.5g/mL strength.
  • Tamsulosin HCl Capsules Alpha-1 adrenergic receptor antagonist capsules for BPH, 0.4mg strength.
  • Topiramate Tablets Anticonvulsant tablets for epilepsy and migraine prevention, 25mg-200mg strengths.
  • Venlafaxine ER Tablets SNRI extended-release tablets for depression and anxiety disorders, 37.5mg-225mg strengths.

Companies that use Ascent Pharmaceuticals

Customer profile

Segments2 records

Ideal customer profiles2 records

Ascent Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ascent Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and strategic.

  • Camber Pharmaceuticals, Inc.coreChannel Partner/ Reseller/ DistributorStrategic commercial partnership where Ascent's manufacturing excellence and supply execution capabilities are combined with Camber's commercial leadership, marketing strength, and customer-facing expertise. Ascent's commercial products are primarily marketed and distributed under the Camber brand, enabling a coordinated, reliable, and market-responsive approach to serving healthcare partners nationwide.
  • XLCare PharmaceuticalscoreChannel Partner/ Reseller/ DistributorPartnership with XLCare Pharmaceuticals to support U.S. government healthcare programs and the patients and communities they serve, including Medicaid, Medicare, and other federal/state healthcare programs.
  • Asphar LaboratoriesstrategicStrategic or Co-development PartnerIndia-based R&D counterpart that collaborates with Ascent Pharmaceuticals to support select early-stage formulation and analytical development, enhancing Ascent's product development pipeline.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Ascent Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Lannett Company: US-based generic pharmaceutical manufacturer of comparable scale with a portfolio overlapping Ascent's CNS stimulant, opioid, and cardiovascular generics. Lannett is one of Ascent's distribution channel partners, underscoring direct comparability in product mix and customer base.
  • Amneal Pharmaceuticals: US-headquartered generic and specialty pharmaceutical company with a portfolio that directly overlaps Ascent's CNS stimulant, opioid, and injectable offerings. Comparable scale, US manufacturing footprint, and exposure to complex generics and controlled substances.
  • Camber Pharmaceuticals: Sister-concern US generic distributor (also under Hetero Labs) and Ascent's primary commercial channel partner. Operates a near-identical generic portfolio across controlled substances, CNS, and pain management — competing head-to-head in the same molecules and customer accounts.
  • Glenmark Pharmaceuticals (US): India-headquartered generic manufacturer with a meaningful US commercial presence. Overlapping dosage forms (tablets, capsules, oral solutions) and therapeutic categories including CNS, cardiovascular, and pain.
  • Ascend Laboratories (Alkem Labs US arm): US generics subsidiary of Alkem Laboratories with a portfolio and operational footprint closely aligned with Ascent's — private-equity-backed, broad therapeutic mix, and India-linked R&D support. Competes for the same ANDA opportunities and channel relationships.

Broad incumbents

  • Endo International: US specialty/generic pharma company with a strong controlled-substance and pain-management franchise (Par Pharmaceutical). Comparable focus on Schedule II generics and complex formulations at greater scale.
  • Zydus Pharmaceuticals (USA): US generics arm of Cadila/Zydus, an India-based group with deep R&D ties to Ascent's partner Asphar Laboratories. Portfolio overlaps significantly across cardiovascular, CNS, and pain generics.
  • Aurobindo Pharma USA: US arm of one of the largest global generic manufacturers. Overlaps with Ascent across multiple therapeutic categories and dosage forms, but at substantially greater scale and breadth — a relevant comparable for trajectory benchmarking.
  • Sun Pharmaceutical Industries (US): India-headquartered global generics leader with significant US operations through Taro Pharmaceutical. Overlaps with Ascent across CNS, cardiovascular, and pain categories; relevant for scale and capacity benchmarking.

Regional players

  • Apotex Corp. Canadian-headquartered generic manufacturer with a sizable US business across tablets, capsules, and oral solutions. Overlapping product formats and therapeutic categories, with a comparable focus on quality manufacturing and regulated markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Ascent Pharmaceuticals social profiles

Digital presence

Ascent Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ascent Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles5 records

Ascent Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ascent Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascent Pharmaceuticals

What does Ascent Pharmaceuticals do?

Ascent Pharmaceuticals develops, manufactures, and analyzes high-quality generic medicines at a 309,000+ square foot cGMP-compliant facility in Central Islip, New York. The company produces a portfolio of 49 generic pharmaceutical products spanning multiple dosage forms (tablets, capsules, softgels, films, and oral solutions) across therapeutic categories including CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed and distributed primarily through channel partners Camber Pharmaceuticals and XLCare Pharmaceuticals, with select products sold under the Ascent brand.

Is Ascent Pharmaceuticals a public or private company?

Ascent Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ascent Pharmaceuticals founded?

Ascent Pharmaceuticals was founded in 2012. It employs 101 to 250 people.

Where is Ascent Pharmaceuticals based?

Ascent Pharmaceuticals is headquartered in Central Islip, United States, in the North America region.

How does Ascent Pharmaceuticals make money?

One revenue line is on record: generic Pharmaceutical Product Sales.

Who are Ascent Pharmaceuticals's main competitors?

Direct peers on record are Lannett Company, Amneal Pharmaceuticals, Camber Pharmaceuticals, Glenmark Pharmaceuticals (US) and Ascend Laboratories (Alkem Labs US arm). Broad incumbents are Endo International, Zydus Pharmaceuticals (USA), Aurobindo Pharma USA and Sun Pharmaceutical Industries (US). Apotex Corp. is listed as a regional player.

Does Ascent Pharmaceuticals have an API?

No public API is recorded for Ascent Pharmaceuticals.

What industry is Ascent Pharmaceuticals in?

Ascent Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIABAG, Generic APIs & Intermediates (Active Ingredients). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals